Edition:
India

Shilpa Medicare Gets USFDA Final Approval For Its ANDA, Docetaxel Injection


Friday, 17 May 2019 

May 17 (Reuters) - Shilpa Medicare Ltd ::SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, DOCETAXEL INJECTION. 

Related Company News

Company Quote

268.4
3.7 +1.40%
3:40pm IST